These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 21483109)
1. LRRK2 G2019S mutation does not contribute to Parkinson's disease in South India. Vijayan B; Gopala S; Kishore A Neurol India; 2011; 59(2):157-60. PubMed ID: 21483109 [TBL] [Abstract][Full Text] [Related]
2. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect? Orr-Urtreger A; Shifrin C; Rozovski U; Rosner S; Bercovich D; Gurevich T; Yagev-More H; Bar-Shira A; Giladi N Neurology; 2007 Oct; 69(16):1595-602. PubMed ID: 17938369 [TBL] [Abstract][Full Text] [Related]
3. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia. Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990 [TBL] [Abstract][Full Text] [Related]
4. Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: importance of G2019S and R1441C mutations in sporadic Parkinson's disease patients. Floris G; Cannas A; Solla P; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Sardu C; Marrosu F; Marrosu MG Parkinsonism Relat Disord; 2009 May; 15(4):277-80. PubMed ID: 18805725 [TBL] [Abstract][Full Text] [Related]
5. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822 [TBL] [Abstract][Full Text] [Related]
6. Fall risk and gait in Parkinson's disease: the role of the LRRK2 G2019S mutation. Mirelman A; Heman T; Yasinovsky K; Thaler A; Gurevich T; Marder K; Bressman S; Bar-Shira A; Orr-Urtreger A; Giladi N; Hausdorff JM; Mov Disord; 2013 Oct; 28(12):1683-90. PubMed ID: 24123150 [TBL] [Abstract][Full Text] [Related]
7. Lrrk2 mutations in South America: A study of Chilean Parkinson's disease. Perez-Pastene C; Cobb SA; Díaz-Grez F; Hulihan MM; Miranda M; Venegas P; Godoy OT; Kachergus JM; Ross OA; Layson L; Farrer MJ; Segura-Aguilar J Neurosci Lett; 2007 Jul; 422(3):193-7. PubMed ID: 17614198 [TBL] [Abstract][Full Text] [Related]
8. LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance. Gaig C; Ezquerra M; Marti MJ; Muñoz E; Valldeoriola F; Tolosa E Arch Neurol; 2006 Mar; 63(3):377-82. PubMed ID: 16533964 [TBL] [Abstract][Full Text] [Related]
9. Dyskinesias in patients with Parkinson's disease: effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation. Yahalom G; Kaplan N; Vituri A; Cohen OS; Inzelberg R; Kozlova E; Korczyn AD; Rosset S; Friedman E; Hassin-Baer S Parkinsonism Relat Disord; 2012 Nov; 18(9):1039-41. PubMed ID: 22703868 [TBL] [Abstract][Full Text] [Related]
10. Genetic screening for LRRK2 gene G2019S mutation in Parkinson's disease patients from Southern Italy. De Rosa A; Criscuolo C; Mancini P; De Martino M; Giordano IA; Pappatà S; Filla A; De Michele G Parkinsonism Relat Disord; 2009 Mar; 15(3):242-4. PubMed ID: 18621566 [TBL] [Abstract][Full Text] [Related]
12. Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis. Agalliu I; San Luciano M; Mirelman A; Giladi N; Waro B; Aasly J; Inzelberg R; Hassin-Baer S; Friedman E; Ruiz-Martinez J; Marti-Masso JF; Orr-Urtreger A; Bressman S; Saunders-Pullman R JAMA Neurol; 2015 Jan; 72(1):58-65. PubMed ID: 25401981 [TBL] [Abstract][Full Text] [Related]
13. Genetic screening for the LRRK2 R1441C and G2019S mutations in Parkinsonian patients from Campania. De Rosa A; De Michele G; Guacci A; Carbone R; Lieto M; Peluso S; Picillo M; Barone P; Salemi F; Laiso A; Saccà F; Tessitore A; Pellecchia MT; Bonifati V; Criscuolo C J Parkinsons Dis; 2014; 4(1):123-8. PubMed ID: 24496098 [TBL] [Abstract][Full Text] [Related]
14. G2019S mutation of the leucine-rich repeat kinase 2 gene in a cohort of Egyptian patients with Parkinson's disease. Hashad DI; Abou-Zeid AA; Achmawy GA; Allah HM; Saad MA Genet Test Mol Biomarkers; 2011 Dec; 15(12):861-6. PubMed ID: 21699405 [TBL] [Abstract][Full Text] [Related]
15. [Clinical features of LRRK2-associated Parkinson's disease]. Pchelina SN; Ivanova ON; Emel'ianov AK; Iakimovskiĭ AF Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(12):56-62. PubMed ID: 22433811 [TBL] [Abstract][Full Text] [Related]
16. Identification of candidate genes for Parkinson's disease through blood transcriptome analysis in LRRK2-G2019S carriers, idiopathic cases, and controls. Infante J; Prieto C; Sierra M; Sánchez-Juan P; González-Aramburu I; Sánchez-Quintana C; Berciano J; Combarros O; Sainz J Neurobiol Aging; 2015 Feb; 36(2):1105-9. PubMed ID: 25475535 [TBL] [Abstract][Full Text] [Related]
17. The LRRK2 R1441C mutation is more frequent than G2019S in Parkinson's disease patients from southern Italy. Criscuolo C; De Rosa A; Guacci A; Simons EJ; Breedveld GJ; Peluso S; Volpe G; Filla A; Oostra BA; Bonifati V; De Michele G Mov Disord; 2011 Aug; 26(9):1733-6. PubMed ID: 21538529 [TBL] [Abstract][Full Text] [Related]
18. Low frequency of common LRRK2 mutations in Mexican patients with Parkinson's disease. Yescas P; López M; Monroy N; Boll MC; Rodríguez-Violante M; Rodríguez U; Ochoa A; Alonso ME Neurosci Lett; 2010 Nov; 485(2):79-82. PubMed ID: 20727385 [TBL] [Abstract][Full Text] [Related]
19. Motor progression of Parkinson's disease with the leucine-rich repeat kinase 2 G2019S mutation. Yahalom G; Orlev Y; Cohen OS; Kozlova E; Friedman E; Inzelberg R; Hassin-Baer S Mov Disord; 2014 Jul; 29(8):1057-60. PubMed ID: 24903616 [TBL] [Abstract][Full Text] [Related]
20. High frequency and reduced penetrance of LRRK2 G2019S mutation among Parkinson's disease patients in Cantabria (Spain). Sierra M; González-Aramburu I; Sánchez-Juan P; Sánchez-Quintana C; Polo JM; Berciano J; Combarros O; Infante J Mov Disord; 2011 Nov; 26(13):2343-6. PubMed ID: 21954089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]